Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | “Anticoagulants - Competitive Landscape and Pipeline Insights, 2015”- A DelveInsight’s ReportDelveInsight, the leading market research and consulting company has added a new report “Anticoagulants - Competitive Landscape and Pipeline Insights, 2015” to its portfolio.
By: DelveInsight Business Research · 17+ pipeline drugs with 14+ companies actively involved in drug development. There are 2 drugs in phase III, 4 in phase II, 5 in phase I, 4 in pre-clinical and 2 in discovery. · Portola Pharmaceuticals is developing a lead product Batrixaban which is in Phase III. · R& · Therapeutic assessments by molecule types, route of administration, monotherapy and combination products. · Information related to collaborations, in-licensing and out-licensing deals. DelveInsights, Anticoagulants - Competitive Landscape and Pipeline Insights, 2015 report provides the in-depth analysis of Anticoagulants - Competitive Landscape across the globe. Therefore the report on Anticoagulants - Competitive Landscape and Pipeline Insights provides information on chemical, technology information and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight is offering the Report at a price of USD 1,750 as a single user license, USD 3,500 as a site license and USD 5,000 as a Global/Enterprise License. For more information on Anticoagulants - Competitive Landscape and Pipeline Insights, 2015 report, email at info@delveInsight.com Contact Us: DelveInsight Business Research New Delhi-110075, India Phone: +91-11-45689769, +91 9650213330 Website: http://delveinsight.com About Us DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making; End
|
|